Trinity Biotech annual debt-to-equity ratio
2015
2016
2017
2018
2019
Trinity Biotech Debt-to-Equity Ratio Growth & History (TRIB)
Trinity Biotech's debt-to-equity ratio was 0.22 for fiscal 2019.
View full Trinity Biotech company overviewTrinity Biotech annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2019 | 2019-12-31 | 0.22 | −2.05 | −90.25% |
| 2018 | 2018-12-31 | 2.27 | 2.25 | +14088.40% |
| 2017 | 2017-12-31 | 0.02 | 0.01 | +66.77% |
| 2016 | 2016-12-31 | 0.01 | 0.01 | +204886.31% |
| 2015 | 2015-12-31 | 0.00 | — | — |
Trinity Biotech quarterly debt-to-equity ratio
Q4.17
Q4.18
Q4.19
Q2.22
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2022 | 2022-06-30 | 0.93 | — | — |
| Q4 2019 | 2019-12-31 | 0.22 | −2.05 | −90.25% |
| Q4 2018 | 2018-12-31 | 2.27 | 2.25 | +14088.40% |
| Q4 2017 | 2017-12-31 | 0.02 | — | — |
Trinity Biotech debt-to-equity ratio trends
Between the periods ended 2015-12-31 and 2019-12-31, Trinity Biotech's debt-to-equity ratio increased from 0.00 to 0.22, a change of 0.22. The latest reported quarter, Q2 2022, shows 0.93.
About the metric
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
Calculation and source
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Trinity Biotech source filings ↗